126 related articles for article (PubMed ID: 34082881)
21. Folate-conjugated pluronic/polylactic acid polymersomes for oral delivery of paclitaxel.
Pan XQ; Gong YC; Li ZL; Li YP; Xiong XY
Int J Biol Macromol; 2019 Oct; 139():377-386. PubMed ID: 31377294
[TBL] [Abstract][Full Text] [Related]
22. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
Liu Y; Sun J; Cao W; Yang J; Lian H; Li X; Sun Y; Wang Y; Wang S; He Z
Int J Pharm; 2011 Dec; 421(1):160-9. PubMed ID: 21945183
[TBL] [Abstract][Full Text] [Related]
23. Functionalized Graphene Oxide as a nanocarrier of new Copper (II) complexes for targeted therapy on nasopharyngeal carcinoma.
Li G; Yang Y; Zhou R; Meng F; Li X
Eur J Pharm Sci; 2018 Oct; 123():249-259. PubMed ID: 29981404
[TBL] [Abstract][Full Text] [Related]
24. Polypeptide-based combination of paclitaxel and cisplatin for enhanced chemotherapy efficacy and reduced side-effects.
Song W; Tang Z; Li M; Lv S; Sun H; Deng M; Liu H; Chen X
Acta Biomater; 2014 Mar; 10(3):1392-402. PubMed ID: 24316362
[TBL] [Abstract][Full Text] [Related]
25. Tumor-targeted paclitaxel-loaded folate conjugated poly(ethylene glycol)-poly(L-lactide) microparticles produced by supercritical fluid technology.
Huang X; Zhang Y; Yin G; Pu X; Liao X; Huang Z; Chen X; Yao Y
J Mater Sci Mater Med; 2015 Feb; 26(2):95. PubMed ID: 25649516
[TBL] [Abstract][Full Text] [Related]
26. Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer.
Hijaz M; Das S; Mert I; Gupta A; Al-Wahab Z; Tebbe C; Dar S; Chhina J; Giri S; Munkarah A; Seal S; Rattan R
BMC Cancer; 2016 Mar; 16():220. PubMed ID: 26979107
[TBL] [Abstract][Full Text] [Related]
27. A novel preparation method of paclitaxcel-loaded folate-modified chitosan microparticles and in vitro evaluation.
Wang F; Yang S; Hua D; Yuan J; Huang C; Gao Q
J Biomater Sci Polym Ed; 2016; 27(3):276-89. PubMed ID: 26578298
[TBL] [Abstract][Full Text] [Related]
28. Graphene oxide sensitizes cancer cells to chemotherapeutics by inducing early autophagy events, promoting nuclear trafficking and necrosis.
Lin KC; Lin MW; Hsu MN; Yu-Chen G; Chao YC; Tuan HY; Chiang CS; Hu YC
Theranostics; 2018; 8(9):2477-2487. PubMed ID: 29721093
[No Abstract] [Full Text] [Related]
29. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle.
Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A
Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785
[TBL] [Abstract][Full Text] [Related]
30. PEGylated graphene oxide for tumor-targeted delivery of paclitaxel.
Xu H; Fan M; Elhissi AM; Zhang Z; Wan KW; Ahmed W; Phoenix DA; Sun X
Nanomedicine (Lond); 2015; 10(8):1247-62. PubMed ID: 25955123
[TBL] [Abstract][Full Text] [Related]
31. Folate and CD44 receptors dual-targeting hydrophobized hyaluronic acid paclitaxel-loaded polymeric micelles for overcoming multidrug resistance and improving tumor distribution.
Liu Y; Sun J; Lian H; Cao W; Wang Y; He Z
J Pharm Sci; 2014 May; 103(5):1538-47. PubMed ID: 24619562
[TBL] [Abstract][Full Text] [Related]
32. Delivery of paclitaxel using PEGylated graphene oxide as a nanocarrier.
Xu Z; Zhu S; Wang M; Li Y; Shi P; Huang X
ACS Appl Mater Interfaces; 2015 Jan; 7(2):1355-63. PubMed ID: 25546399
[TBL] [Abstract][Full Text] [Related]
33. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N
Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839
[TBL] [Abstract][Full Text] [Related]
34. A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy.
Shan L; Zhuo X; Zhang F; Dai Y; Zhu G; Yung BC; Fan W; Zhai K; Jacobson O; Kiesewetter DO; Ma Y; Gao G; Chen X
Theranostics; 2018; 8(7):2018-2030. PubMed ID: 29556370
[TBL] [Abstract][Full Text] [Related]
35. Design, Synthesis, and Characterization of Folate-Targeted Platinum-Loaded Theranostic Nanoemulsions for Therapy and Imaging of Ovarian Cancer.
Patel NR; Piroyan A; Nack AH; Galati CA; McHugh M; Orosz S; Keeler AW; O'Neal S; Zamboni WC; Davis B; Coleman TP
Mol Pharm; 2016 Jun; 13(6):1996-2009. PubMed ID: 27170232
[TBL] [Abstract][Full Text] [Related]
36. Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer.
He Z; Shi Z; Sun W; Ma J; Xia J; Zhang X; Chen W; Huang J
Tumour Biol; 2016 Jun; 37(6):7809-21. PubMed ID: 26695149
[TBL] [Abstract][Full Text] [Related]
37. Folate-appended cyclodextrin carrier targets ovarian cancer cells expressing the proton-coupled folate transporter.
Saito S; Koya Y; Kajiyama H; Yamashita M; Kikkawa F; Nawa A
Cancer Sci; 2020 May; 111(5):1794-1804. PubMed ID: 32154964
[TBL] [Abstract][Full Text] [Related]
38. [Preparation of folate-targeted magnetic nanocomposites loaded with TFPI-2 plasmid and cisplatin and evaluation of its targeting and inhibitory effect on nasopharyngeal carcinoma HNE-1 cells in vitro].
Liu RZ; Zhang J; Liu T; Fu XY; Zhang LM; Xie MQ
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(25):2023-30. PubMed ID: 27470963
[TBL] [Abstract][Full Text] [Related]
39. Covalent functionalization of graphene oxide with biocompatible poly(ethylene glycol) for delivery of paclitaxel.
Xu Z; Wang S; Li Y; Wang M; Shi P; Huang X
ACS Appl Mater Interfaces; 2014 Oct; 6(19):17268-76. PubMed ID: 25216036
[TBL] [Abstract][Full Text] [Related]
40. Investigation of graphene-based nanomaterial as nanocarrier for adsorption of paclitaxel anticancer drug: a molecular dynamics simulation study.
Hasanzade Z; Raissi H
J Mol Model; 2017 Feb; 23(2):36. PubMed ID: 28120117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]